Cargando…
Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer
Platinum resistance is an important cause of clinical recurrence and mortality of patients with high-grade serous ovarian cancer (HGSOC). Methyl-CpG binding domain protein 2 (MBD2) serves an important role in tumor progression; however, its role in HGSOC remains unclear. The aim of the present study...
Autores principales: | Gong, Wangang, Ni, Maowei, Chen, Zhongbo, Zheng, Zhiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400232/ https://www.ncbi.nlm.nih.gov/pubmed/32782591 http://dx.doi.org/10.3892/ol.2020.11836 |
Ejemplares similares
-
Densely methylated DNA traps Methyl-CpG–binding domain protein 2 but permits free diffusion by Methyl-CpG–binding domain protein 3
por: Leighton, Gage O., et al.
Publicado: (2022) -
Comparative study of methyl-CpG-binding domain proteins
por: Roloff, Tim C, et al.
Publicado: (2003) -
The Effects of O(6)-methyl Guanine DNA-methyl Transferase Promotor Methylation and CpG1, CpG2, CpG3 and CpG4 Methylation on Treatment Response and their Prognostic Significance in Patients with Glioblastoma
por: Yildiz, OG, et al.
Publicado: (2020) -
Recognition of methylated DNA through methyl-CpG binding domain proteins
por: Zou, Xueqing, et al.
Publicado: (2012) -
5-Halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)
por: Valinluck, Victoria, et al.
Publicado: (2005)